EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Cambier, Samantha; Sylvester, Richard; Collette, Laurence; Gontero, Paolo; Brausi, Maurizio; van Andel, George; Kirkels, Wim; Da Silva, Fernando; Oosterlinck, Willem; Prescott, Stephen; Kirkali, Ziya; Powell, Philip; de Reijke, Theo; Turkeri, LEVENT; Collette, Sandra; Oddens, Jorg

doi:10.1016/j.eururo.2015.06.045

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Copy For Citation

Cambier S., Sylvester R. J., Collette L., Gontero P., Brausi M. A., van Andel G., ...More

EUROPEAN UROLOGY, vol.69, no.1, pp.60-69, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 69 Issue: 1
Publication Date: 2016
Doi Number: 10.1016/j.eururo.2015.06.045
Journal Name: EUROPEAN UROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.60-69
Keywords: Non-muscle-invasive bladder cancer, Prognostic factors, Recurrence, Progression, Survival, Bacillus Calmette-Guerin, TRANSITIONAL-CELL CARCINOMA, PROGNOSTIC-FACTORS, FOLLOW-UP, TA, T1, IMMUNOTHERAPY, INSTILLATIONS, TABLES, MODEL
Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC) treated with 1-3 yr of maintenance bacillus Calmette-Guerin (BCG).